These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 38352058)
1. From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation. Yang S; Jing S; Wang S; Jia F Front Cell Infect Microbiol; 2024; 14():1303645. PubMed ID: 38352058 [TBL] [Abstract][Full Text] [Related]
2. Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions. Kamali A; Ziadlou R; Lang G; Pfannkuche J; Cui S; Li Z; Richards RG; Alini M; Grad S Theranostics; 2021; 11(1):27-47. PubMed ID: 33391459 [TBL] [Abstract][Full Text] [Related]
3. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain? Li W; Lai K; Chopra N; Zheng Z; Das A; Diwan AD Eur Spine J; 2022 Apr; 31(4):917-925. PubMed ID: 35286474 [TBL] [Abstract][Full Text] [Related]
4. Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc. Feng C; Liu H; Yang Y; Huang B; Zhou Y Cell Physiol Biochem; 2015; 35(1):1-16. PubMed ID: 25547527 [TBL] [Abstract][Full Text] [Related]
5. MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration. Zhang HJ; Liao HY; Bai DY; Wang ZQ; Xie XW Biomed Pharmacother; 2021 Nov; 143():112170. PubMed ID: 34536759 [TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. Hughes SP; Freemont AJ; Hukins DW; McGregor AH; Roberts S J Bone Joint Surg Br; 2012 Oct; 94(10):1298-304. PubMed ID: 23015552 [TBL] [Abstract][Full Text] [Related]
8. Differentiation of Pluripotent Stem Cells into Nucleus Pulposus Progenitor Cells for Intervertebral Disc Regeneration. Xia K; Gong Z; Zhu J; Yu W; Wang Y; Wang J; Xu A; Zhou X; Tao H; Li F; Liang C Curr Stem Cell Res Ther; 2019; 14(1):57-64. PubMed ID: 30227822 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment. Wang Y; Cheng H; Wang T; Zhang K; Zhang Y; Kang X Cell Prolif; 2023 Sep; 56(9):e13448. PubMed ID: 36915968 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and therapeutic implications of matrix metalloproteinases in intervertebral disc degeneration: A comprehensive review. Zou X; Zhang X; Han S; Wei L; Zheng Z; Wang Y; Xin J; Zhang S Biochimie; 2023 Nov; 214(Pt B):27-48. PubMed ID: 37268183 [TBL] [Abstract][Full Text] [Related]
11. The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain. Zhang S; Hu B; Liu W; Wang P; Lv X; Chen S; Shao Z Osteoarthritis Cartilage; 2021 Jan; 29(1):17-27. PubMed ID: 33007412 [TBL] [Abstract][Full Text] [Related]
12. Leptin and the intervertebral disc: a biochemical link exists between obesity, intervertebral disc degeneration and low back pain-an in vitro study in a bovine model. Segar AH; Fairbank JCT; Urban J Eur Spine J; 2019 Feb; 28(2):214-223. PubMed ID: 30324498 [TBL] [Abstract][Full Text] [Related]
13. Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration. Mohd Isa IL; Teoh SL; Mohd Nor NH; Mokhtar SA Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613651 [TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy. Zhang XB; Hu YC; Cheng P; Zhou HY; Chen XY; Wu D; Zhang RH; Yu DC; Gao XD; Shi JT; Zhang K; Li SL; Song PJ; Wang KP Int J Med Sci; 2021; 18(13):2799-2813. PubMed ID: 34220308 [TBL] [Abstract][Full Text] [Related]
15. Intervertebral Disc Degeneration Models for Pathophysiology and Regenerative Therapy -Benefits and Limitations. Wang Y; Kang J; Guo X; Zhu D; Liu M; Yang L; Zhang G; Kang X J Invest Surg; 2022 Apr; 35(4):935-952. PubMed ID: 34309468 [No Abstract] [Full Text] [Related]
16. Applications of Functionalized Hydrogels in the Regeneration of the Intervertebral Disc. Yan C; Wang X; Xiang C; Wang Y; Pu C; Chen L; Jiang K; Li Y Biomed Res Int; 2021; 2021():2818624. PubMed ID: 34458364 [TBL] [Abstract][Full Text] [Related]
17. Tissue Renin-Angiotensin System (tRAS) Induce Intervertebral Disc Degeneration by Activating Oxidative Stress and Inflammatory Reaction. Sun K; Sun X; Sun J; Jiang Y; Lin F; Kong F; Li F; Zhu J; Huan L; Zheng B; Wang Y; Zou W; Gao L; Xu X; Shi J Oxid Med Cell Longev; 2021; 2021():3225439. PubMed ID: 34413926 [TBL] [Abstract][Full Text] [Related]
18. Regulatory Effect of Inflammatory Mediators in Intervertebral Disc Degeneration. Li Z; Yang H; Hai Y; Cheng Y Mediators Inflamm; 2023; 2023():6210885. PubMed ID: 37101594 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of biological aging in intervertebral discs. Vo NV; Hartman RA; Patil PR; Risbud MV; Kletsas D; Iatridis JC; Hoyland JA; Le Maitre CL; Sowa GA; Kang JD J Orthop Res; 2016 Aug; 34(8):1289-306. PubMed ID: 26890203 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials of intervertebral disc regeneration: current status and future developments. Sun Y; Leung VY; Cheung KM Int Orthop; 2019 Apr; 43(4):1003-1010. PubMed ID: 30498908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]